EUROPEAN NEUROPSYCHOPHARMACOLOGY
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
Inhaltsverzeichnis
- 293
-
Social cognition in first-degree relatives of patients with bipolar disorder: A meta-analysisBora, Emre / Özerdem, Ayşegül et al. | 2017
- 301
-
EEG connectivity between the subgenual anterior cingulate and prefrontal cortices in response to antidepressant medicationIseger, Tabitha A. / Korgaonkar, Mayuresh S. / Kenemans, J. Leon et al. | 2017
- 313
-
Dopamine D3 and acetylcholine nicotinic receptor heteromerization in midbrain dopamine neurons: Relevance for neuroplasticityBontempi, Leonardo / Savoia, Paola / Bono, Federica et al. | 2017
- 325
-
Partial agonism at the α7 nicotinic acetylcholine receptor improves attention, impulsive action and vigilance in low attentive ratsHayward, Andrew / Adamson, Lisa / Neill, Joanna C. et al. | 2017
- 336
-
The involvement of cannabinoids and mTOR in the reconsolidation of an emotional memory in the hippocampal–amygdala–insular circuitZubedat, Salman / Akirav, Irit et al. | 2017
- 350
-
Do patients with bipolar disorder and subsyndromal symptoms benefit from functional remediation? A 12-month follow-up studySanchez-Moreno, Jose / Bonnín, Caterina / González-Pinto, Ana et al. | 2017
- 360
-
CRHR1 promoter hypomethylation: An epigenetic readout of panic disorder?Schartner, Christoph / Ziegler, Christiane / Schiele, Miriam A. et al. | 2017
- 372
-
Neural underpinnings of prosexual effects induced by gamma-hydroxybutyrate in healthy male humansBosch, Oliver G. / Havranek, Michael M. / Baumberger, Andrea et al. | 2017
- 383
-
Clozapine as the most efficacious antipsychotic for activating ERK 1/2 kinases: Role of 5-HT2A receptor agonismAringhieri, Stefano / Kolachalam, Shivakumar / Gerace, Claudio et al. | 2017
- 399
-
Noradrenaline transporter blockade increases fronto-parietal functional connectivity relevant for working memoryHernaus, Dennis / Casales Santa, Marta Ma / Offermann, Jan Stefan et al. | 2017
- 411
-
The novel antipsychotic drug brexpiprazole, alone and in combination with escitalopram, facilitates prefrontal glutamatergic transmission via a dopamine D1 receptor-dependent mechanismBjörkholm, Carl / Marcus, Monica M. / Konradsson-Geuken, Åsa et al. | 2017
- 418
-
Evidence-based national suicide prevention taskforce in Europe: A consensus position paperZalsman, Gil / Hawton, Keith / Wasserman, Danuta et al. | 2017
- iii
-
Contents| 2017
- S521
-
Abstracts of the 30th ECNP Congress| 2017
- S521
-
Endophenotypes in schizophreniaFreedman, R. et al. | 2017
- S522
-
From genes to clinical phenotype in ADHD across the lifespanFranke, B. et al. | 2017
- S525
-
Exome or whole genome sequencing in bipolar disorderKato, T. et al. | 2017
- S526
-
When she's gone: oxytocin reverses partner loss-induced passive stress copingBosch, O. et al. | 2017
- S527
-
The role of serotonin and reward circuit architecture in oxytocin promoted social cognition: neuroimaging insightsFrokjaer, V.G. et al. | 2017
- S528
-
Re-examining the antidepressant potential and mechanisms of isofluraneRantamäki, T. et al. | 2017
- S530
-
Synaptic basis of cocaine addictionPascoli, V. et al. | 2017
- S531
-
Habit formation in humans with cocaine addictionErsche, K.D. et al. | 2017
- S533
-
SERT gene variation and response to exposure therapy in agoraphobiaSchruers, K. et al. | 2017
- S534
-
From candidate gene to (epi)genome-wide analysis of therapy response in adult anxiety disordersDomschke, K. / Ziegler, C. / Richter, J. et al. | 2017
- S536
-
Genome-wide association analysis implicates microRNAs in bipolar affective disorderForstner, A.J. / Maaser, A. / Sumer, S. et al. | 2017
- S537
-
Ketamine restores changes in glutamate release, dendrite morphology and BDNF trafficking in the hippocampus of rats vulnerable to chronic mild stressTornese, P. / Musazzi, L. / Sala, N. et al. | 2017
- S538
-
A novel approach to map induced activation of neuronal networks using chemogenetics and functional neuroimagingRoelofs, T.J.M. / Verharen, J.P.H. / Van Tilborg, G.A.F. et al. | 2017
- S539
-
Role of the matricellular protein hevin in drug responseMongredien, R. / Yau, A. / Rezai Amin, S. et al. | 2017
- S540
-
Emerging novel psychoactive substances in EuropeTorrens, M. et al. | 2017
- S541
-
Behavioural toxicology and metabolomics of novel psychoactive substances (NPS) in controlled human studiesRamaekers, J. et al. | 2017
- S542
-
The KEEP-WELL trial (NCT02414932) – ketamine for depression relapse prevention following ECTMcLoughlin, D. / Finnegan, M. / Ryan, K. et al. | 2017
- S543
-
The concept of resilience: definition and measurementKane, J.M. et al. | 2017
- S544
-
Dopamine and resilience in schizophrenia: a review and clinical implicationsUchida, H. / Suzuki, T. / Yagi, G. et al. | 2017
- S545
-
Glucocorticoid receptor-dependent signalling in astrocytes as target of opioid actionBarut, J. / Skupio, U. / Tertil, M. et al. | 2017
- S546
-
Mineralocorticoid receptor and cognitive function in major depressionKaczmarczyk, M. / Otte, C. / Wingenfeld, K. et al. | 2017
- S547
-
Acute psychosocial stress impacts the hemodynamic response latency: a novel brain-phenotype of acute stress and GR-sensitivityElbau, I. / Bruecklmeier, B. / Arloth, J. et al. | 2017
- S548
-
Can we weaken or rewrite maladaptive alcohol memories via reconsolidation?Das, R. / Walsh, K. / Lawn, W. et al. | 2017
- S549
-
Sex differences in neuroplasticity and neurosteroids effectsGarcia-Segura, L.M. / Melcangi, R.C. et al. | 2017
- S550
-
Clinical studies on comorbidity of internet gaming disorders with mood, anxiety and personality disordersWeinstein, A. et al. | 2017
- S551
-
Aerobic exercise interventions as feasible and effective interventions for schizophreniaMalchow, B. et al. | 2017
- S554
-
Understanding complex inputs to an abnormal circuitry in the trisynaptic pathway in schizophreniaBenes, F.M. et al. | 2017
- S556
-
Brain-computer interface using high-density intracortical microelectrode arrays for robotic limb control and reliable communicationJarosiewicz, B. et al. | 2017
- S558
-
Clinical studies of epistasis at the level of cognition and other functional aspects of psychotic illnessNicodemus, K. et al. | 2017
- S559
-
Childhood trauma in bipolar disorder: familial continuity and individual mediators for severityEtain, B. et al. | 2017
- S560
-
Childhood trauma and structural and functional brain mechanisms linked to psychopathologyAas, M. et al. | 2017
- S561
-
Ethical considerations about recommending technology for patients with bipolar illnessBauer, M. / Glenn, T. / Bauer, R. et al. | 2017
- S562
-
EEG neurofeedback in ADHD: new metaanalyses and multicentre trialsBrandeis, D. et al. | 2017
- S563
-
Oligodendroglial myelin in cortical circuits: functional roles beyond the axonKole, M. et al. | 2017
- S564
-
Intra-cortical myelination during adolescence: linking MRI networks with gene transcription profilesWhitaker, K. / Vértes, P. / Romero-Garcia, R. et al. | 2017
- S565
-
Fragile X syndrome: from molecular pathology to therapyBardoni, B. / Maurin, T. et al. | 2017
- S566
-
Relationships between inflammation, elevated body mass index, and depressive relapse in bipolar disorderBond, D. / Andreazza, A.C. / Hughes, J. et al. | 2017
- S568
-
Effects of antidepressants on sexual function and satisfaction – implications for drug developmentClayton, A. et al. | 2017
- S569
-
Anxiolytic, hypnotic and analgesic properties of melatonin MT2 receptor partial agonistsGobbi, G. / Lopez-Canul, M. / Ochoa-Sanchez, R. et al. | 2017
- S570
-
Current melatonergic therapies for insomniaZisapel, N. et al. | 2017
- S575
-
Synthetic cannabinoids: clinical aspects and therapy optionsFattore, L. et al. | 2017
- S577
-
PDE7B, NMBR and EPM2A variants and schizophrenia: a case-control and pharmacogenetics studyKim, H. / Jun, T.Y. et al. | 2017
- S578
-
Financial hardship may trigger migraine through circadian dysregulation – a possible role for the CLOCK geneBaksa, D. / Gonda, X. / Edes, A. et al. | 2017
- S579
-
Genome-wide gene-based tests replicate the association of the SORCS3 gene with neuroticismEszlari, N. / Millinghoffer, A. / Petschner, P. et al. | 2017
- S580
-
Gene expression biomarkers related to auditory hallucinations in peripheral blood of patients with schizophreniaGilabert-Juan, J. / Lopez-Campos, G. / Sebastia-Ortega, N. et al. | 2017
- S582
-
Meta-analysis of CYP2C19 association with efficacy and side effects of citalopram and escitalopramFabbri, C. / Tansey, K. / Perlis, R. et al. | 2017
- S583
-
A new target for focusing on neurocognitive symptoms in depression: ATP6V1B2 rs1106634 is associated with hippocampal deficit and lifetime depressionGonda, X. / Eszlari, N. / Baksa, D. et al. | 2017
- S585
-
Genetic association with suicidal ideation in patients with acute coronary syndromeKang, H.J. / Bae, K.Y. / Kim, S.W. et al. | 2017
- S586
-
Translational identification of transcriptional signatures of major depression and antidepressant responseHervé, M. / Bergon, A. / Le Guisquet, A.M. et al. | 2017
- S587
-
Gene expression in the brain of rats with increased aggression and signs of cognitive deficits caused by the early social isolationKrupina, N.A. / Zubkov, E.A. / Zorkina, Y.A. et al. | 2017
- S588
-
A brainstem structural intermediate phenotype of CYP2C19 polymorphismStingl, J.C. / Paul, A. / Steffens, M. et al. | 2017
- S589
-
Assessment of DNA methylation status in HERV-K sequences in patients with first-episode schizophreniaMisiak, B. / Stramecki, F. / Szmida, E. et al. | 2017
- S590
-
Association between polymorphisms of the PCDH15 gene and schizophrenia in Korean populationChoi, Y. / Kang, W. / Kim, E. et al. | 2017
- S591
-
Reduced glutamatergic metabolism in the anterior cingulate cortex in carriers of the Met-allele of the BDNF Val66Met polymorphismMartens, L. / Fensky, L. / Colic, L. et al. | 2017
- S593
-
Distribution of C4 copy number variations in bipolar disorder, schizophrenia and systemic lupus erythematosusMariaselvam, C.M. / Sundaresh, A. / Bennabi, M. et al. | 2017
- S595
-
Genetic and clinical evidence of mitochondrial dysfunction in autism spectrum disorder and intellectual disabilityValiente Pallejà, A. / Muntané, G. / Cortés, M. et al. | 2017
- S597
-
Increased DNA methylation in the parvalbumin gene promoter in schizophrenia – relationship with symptoms and drug treatmentReynolds, G.P. / Fachim, H. / Zeng, L. et al. | 2017
- S598
-
Maternal depression during pregnancy: implications for baby epigenetic signature and stress response systemFarrell, C. / O'Leary, N. / Jairaj, C. et al. | 2017
- S599
-
Histamine H1 receptor level in peripheral blood lymphocytes of schizophrenic patients as possible diagnostic marker of olanzapine treatment efficacyZabotina, A.M. / Taraskina, A.E. / Nasyrova, R.F. et al. | 2017
- S600
-
Incomplete replication of association between DRD2 C957T and cognition in schizophreniaSpitoni, S. / Drago, A. et al. | 2017
- S602
-
A possible GABAergic biomarker for adult autism spectrum disorderMcCracken, J. et al. | 2017
- S603
-
In vivo real-time monitoring of corticostriatal synaptic plasticityCordeiro, C.A. / Koster, T. / Kuhl, L. et al. | 2017
- S604
-
Validating a novel protocadherin 9 conditional knockout mouse model to study sensory cortex functioningHornix, B.E. / Kat, R. / Havekes, R. et al. | 2017
- S605
-
Cerebellum and attention to the eyes in autismLaidi, C. / Boisgontier, J. / Chakravarty, M. et al. | 2017
- S606
-
X-linked PCDH19 protein regulates cortical and hippocampal development, seizure susceptibility, cognition and autism-related behaviorsCwetsch, A. / Perlini, L. / Bassani, S. et al. | 2017
- S607
-
FMRI correlates of social cognition in attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder (ASD) and comorbid conditionIlzarbe, D. / Lukito, S. / O'Daly, O. et al. | 2017
- S608
-
MGlu2 as a novel target underling sex-differences in a ventral dentate gyrus (vDG)-medial amygdala (MeA) circuit controlling social behaviour: importance of early life experiencesNasca, C. / Bigio, B. / Cates, H. et al. | 2017
- S609
-
Dexamethasone upregulates levels of proapoptotic proteins proBDNF and cleaved caspase-3 in the frontal cortex and the hippocampus of neonatal ratsBulygina, V. / Kalinina, T.S. / Lanshakov, D.A. et al. | 2017
- S610
-
GABA-A α5 receptor potentiation in preadolescence prevents hyporeactivity to amphetamine induced by prenatal lipopolysaccharide treatment in rat femalesBatinic, B. / Santrač, A. / Jančić, I. et al. | 2017
- S611
-
Inhibition of DYRK1A overdosage restores cognition in Down syndrome models through DYRK1A-interaction with major players of synaptic transmissionHerault, Y. / Nguyen, T. / Duchon, A. et al. | 2017
- S612
-
Survival effect of embryonic proteoglycans in Alzheimer's disease via simultaneous activation of neurogenesis and angiogenesis in adult brainYenkoyan, K. / Davtyan, T. / Fereshetyan, K. et al. | 2017
- S613
-
Perinatal and early childhood prognosis factors in children with neurodevelopmental disordersKobylinska, L. / Anghel, C. / Rad, F. et al. | 2017
- S615
-
Knockout of the glucocorticoid receptor in astrocytes alters contextual aversive memory in miceSkupio, U. / Kudla, L. / Marut, L. et al. | 2017
- S617
-
Serum VGF levels were significantly changed in mental disorders and may aid the diagnosisYuan, Y. / Chen, S. / Jiang, H. et al. | 2017
- S619
-
Lithium treatment and thyroid function – a retrospective study in patients with unipolar depression, bipolar and schizoaffective disordersSobreira, G. / Oliveira, J. et al. | 2017
- S620
-
The effects of hypocalcaemia on prolactinoma cell populationsMolnar, Z. / Radács, M. / Rácz, L. et al. | 2017
- S621
-
Testosterone application modulates resting-state connectivity in emotion regulation networkVotinov, M. / Wagels, L. / Hoffstaedter, F. et al. | 2017
- S622
-
Peroxiredoxin-1 and peroxiredoxin-3 as indicators of sickness behaviour in patients with varying levels of depression severityOgłodek, E.A. / Just, M.J. / Just, K. et al. | 2017
- S623
-
Mechanism of cortisol production in adrenal cortical cells under the non-stress and stress conditions: role of cyclic AMP and calcium in vitro studyKuwabara, N. / Kurihara, T. / Yoshie, M. et al. | 2017
- S625
-
A study of mechanisms behind extreme aggression: the possible existence of functional signaling mechanisms modulated by ACTH IgGVærøy, H. / Adori, C. / Legrand, R. et al. | 2017
- S626
-
Variation in cytokines and C-reactive protein in different psychiatric disordersSakai, Y. / Iversen, V.C. / Groven, N.H. et al. | 2017
- S627
-
History of depression is associated with neuropsychiatric symptoms and augmented inflammatory markers in a cross sectional study on obese patientsOriolo, G. / Huet, L. / Dexpert, S. et al. | 2017
- S628
-
Selective inhibition of purinergic 2X7 receptors elicits antidepressant-like effect in chronic mild stress model in rats: role of innate immunityAricioglu, F. / Sahin Ozkartal, C. / Bastaskin, T. et al. | 2017
- S630
-
Central and peripheral effects of lipopolysaccharide administration in ratsWadolowska, A. / Myslinska, D. / Podlacha, M. et al. | 2017
- S631
-
Fractalkine alters synaptic activity of rat principal cells in the basolateral amygdalaSowa, J.E. / Tokarski, K. / Hess, G. et al. | 2017
- S632
-
The effect of electroconvulsive therapy (ECT) on serum tryptophan metabolitesMalmei Aarsland, T.I. / Leskauskaite, I. / Midttun, Ø. et al. | 2017
- S633
-
IgG antibodies with nuclease activity in serum of patients with schizophreniaErmakov, E. / Smirnova, L. / Ivanova, S. et al. | 2017
- S634
-
Inflammation in schizophrenia: implications for pathophysiology and treatmentCastanheira, L. / Ferreira, C. / Ferreira, L. et al. | 2017
- S635
-
Β2-microglobulin: a biomarker for bipolar disorder and schizophrenia?Sayous, R. / Manier, C. / Hamdani, N. et al. | 2017
- S636
-
Prolyl endopeptidase is involved in the degradation of neural cell adhesion moleculesJaako, K. / Noortoots, A. / Aonurm-Helm, A. et al. | 2017
- S637
-
Chronic stress triggers Tau pathology through autophagy inhibition and induction of stress granulesSilva, J. / Rodrigues, S. / Marques, M. et al. | 2017
- S639
-
Effect of a single dose of methylphenidate on cognition in adults with attention deficit hyperactivity disorders and predictive therapeutic responseErtle, S. / Vanoli, L. / Erb, A. et al. | 2017
- S641
-
Contrasting effects by blocking orexin and NMDA receptors in telemetric EEG recordings in ratsFerger, B. / Voehringer, P. / Raith, H. et al. | 2017
- S642
-
5-HT1A biased agonists induce different hemodynamic responses: a pharmacological MRI studyVidal, B. / Bolbos, R. / Redouté, J. et al. | 2017
- S643
-
Exploration of the concept of 5-HT1A receptor biased agonists: a multimodal imaging studyVidal, B. / Fieux, S. / Redouté, J. et al. | 2017
- S645
-
Stevens-Johnson syndrome induced by sodium valproate – a case reportNascimento, S. / Freitas, F. / Pereira, D. et al. | 2017
- S647
-
Effects of chronic administration of memantine on okadaic acid induced changes in hippocampus and medial septal nucleusBeselia, G. / Dashniani, M. et al. | 2017
- S648
-
Resveratrol prevents schizophrenia-like behaviour and neural plasticity abnormalities induced by maternal immune activationMoura, N. / Pombo, T. / Ferreira, F. et al. | 2017
- S649
-
Neuronal and peripheral markers of plasticity dynamics, change concomitantly after sub-anesthetic dose of ketamine in humansColic, L. / McDonnell, C. / Li, M. et al. | 2017
- S650
-
Serum concentrations of iNos and IL-33 in depressed patients with a history of suicide attemptsOgłodek, E.A. / Just, M.J. / Moś, D.M. et al. | 2017
- S651
-
Glutamate levels measured by glutamate voltammetry in the rat prefrontal cortex after treatment with N-methyl-D-aspartate receptor antagonistsIonescu, I. / Allers, K. / Arban, R. et al. | 2017
- S652
-
MTOR signaling is involved in the promnesic effects of both 5HT6R agonist and antagonistAsselot, R. / Dauphin, F. / Leger, M. et al. | 2017
- S653
-
Adjunctive aripiprazole in the treatment of risperidone/paliperidone-induced hyperprolactinemia. Influence of catechol-O-methyltransferase and MAOA polymorphismsArnaiz, A. / Zumarraga, M. / Olivas, O. et al. | 2017
- S654
-
Effect of brain-derived neurotrophic factor treatment on behavior and brain serotonin system in tumor necrosis factor-α knockout miceBazovkina, D. / Kulikova, E. / Bazhenova, E. et al. | 2017
- S655
-
The selective orexin-2 antagonist JNJ-42847922(MIN-202) improves sleep in patients with primary insomniaBrooks, S. / Siebenga, P. / Zuiker, R. et al. | 2017
- S656
-
Evaluation of the effects of etifoxine (100 mg) and lorazepam (2 mg) on alertness and cognitive functions in elderly subjectsDeplanque, D. / Machuron, F. / Waucquier, N. et al. | 2017
- S657
-
Modified cinnamic acid derivatives as effective mito- and neuroprotective substancesNeganova, M. / Semenov, V. / Semenova, M. et al. | 2017
- S658
-
Behavioural and hippocampal morphological changes induced by short ketamine treatment in a genetic rat model displaying depressive-like behaviourTreccani, G. / Ardalan, M. / Liebenberg, N. et al. | 2017
- S659
-
Endogenous opioids scale social threat learning in humansHaaker, J. / Yi, J. / Petrovic, P. et al. | 2017
- S660
-
Lumateperone (ITI-007): a novel investigational agent with broad therapeutic potential across multiple neuropsychiatric disordersVanover, K.E. / O'Gorman, C. / Correll, C.U. et al. | 2017
- S661
-
Efficacy of bremelanotide in The RECONNECT StudiesClayton, A. / Lucas, J. / Jordan, R. et al. | 2017
- S662
-
Aβ1-42 impairs mGluR5-gated spike timing-dependent long-term potentiation by disrupting CB1 receptorsLee, J. / Kwag, J.H. et al. | 2017
- S663
-
Endocannabinoid neurotransmission inhibits the formation of nitric oxide in the bed nucleus stria terminalis during acute restraint stress in ratsGomes-de-Souza, L. / Oliveira, L.A. / Benini, R. et al. | 2017
- S664
-
Impact of antipsychotic drugs on neuronal model cells proteomeJankowska, U. / Skupien-Rabian, B. / Swiderska, B. et al. | 2017
- S666
-
Brain-derived neurotrophic factor Val66Met genotype interacts with young-adult stress in neurotransmitter regulation of prepulse inhibition in miceVan den Buuse, M. / Lee, J.J.W. / Jaehne, E. et al. | 2017
- S667
-
Rats exposed to maternal depression and antidepressant treatment during development show sex differences in social behaviorHouwing, D.J. / Ramsteijn, A.S. / Staal, L. et al. | 2017
- S668
-
Scopolamine hydrobromide is indeed a proper memory impairments inductor in micePodkowa, A. / Sałat, K. / Podkowa, K. et al. | 2017
- S669
-
Assessments of the behavioral disorder in the photothrombotic stroke model mouseIto, Y. / Tsuboi, M. / Iguchi, C. et al. | 2017
- S670
-
Analgesic and anti-inflammatory effects of a novel N-pyrrolylcarboxylic acid derivativeZlatanova, H. / Vladimirova, S. / Kandilarov, I. et al. | 2017
- S671
-
Reinforcing properties of the glutamate receptors antagonists and karyotypic stability in ratsBarinova, I. / Potapkin, A.M. / Lebedev, A.A. et al. | 2017
- S673
-
The trace amine-associated receptor 1 modulates nicotine behavioural effectsSukhanov, I. / Dorotenko, A. / Dolgorukova, A. et al. | 2017
- S675
-
Altered serotonergic gene expression in the brain regions of male mice with anxiety/depression-like state and pathology of aggressive behaviourSmagin, D.A. / Kovalenko, I.L. / Galyamina, A.G. et al. | 2017
- S677
-
Reduced aggression, social impairments, and cognitive inflexibility in neuronal nitric oxide (Nos1) knockdown miceO'Leary, A. / Freudenberg, F. / Candemir, E. et al. | 2017
- S678
-
Abnormality of social behavior and dysfunction of autism related gene expression developing under chronic social defeat stress in male miceKudryavtseva, N.N. / Kovalenko, I.L. / Smagin, D.A. et al. | 2017
- S679
-
Comparing models of autism spectrum disorder based on pre- and postnatal valproate exposure: behavioral and histological assessmentGedzun, V. / Dubynin, V. / Malyshev, A. et al. | 2017
- S680
-
Age-related changes in negative affect and cognitive performance in Sprague-Dawley rats: possible role of the cell fate regulator FADDHernández-Hernández, E. / García-Fuster, M.J. et al. | 2017
- S682
-
Gender specific behavioral alterations are associated with gut dysbiosis in mice exposed to multifactorial early-life adversityRincel, M. / Aubert, P. / Chevalier, J. et al. | 2017
- S683
-
Behavioural and peripheral effects of the central nucleus of the amygdala stimulation are more pronounced in high responder ratsRuciński, J. / Myslinska, D. / Wadolowska, A. et al. | 2017
- S684
-
Antinociceptive, antiallodynic and antihyperalgesic activities of NLX-112 in acute, tonic and neuropathic pain models in miceFurgała, A. / Sałat, K. / Kołaczkowski, M. et al. | 2017
- S685
-
50kHz ultrasonic vocalization as a marker of positive affect in mania models: mixed effects induced by ouabainWendler, E. / Souza, C. / Dornellas, A. et al. | 2017
- S686
-
Pharmacological inhibition of gut leakiness prevents the long-term effects of early-life stress in ratsDarnaudéry, M. / Rincel, M. / Minni, A. et al. | 2017
- S687
-
Mesenchymal stem cells secretome: a new therapeutic tool for Parkinson's disease regenerative medicine?Mendes-Pinheiro, B. / Teixeira, F.G. / Anjo, S. et al. | 2017
- S688
-
Differential role of NMDA receptor subunits in the development of PTSD-like symptomsBiro, L. / Sipos, E. / Miskolczi, C. et al. | 2017
- S689
-
Activation of the nigrostriatal dopaminergic pathway increases prepulse-inhibition of the startle response in female but not in male Long Evans ratsCasado, A. / Baerentzen, S. / Kjaerby, C. et al. | 2017
- S690
-
Down syndrome model characterization: adult and post-natal neurogenesis enhancement with selective α5 GABA-A modulator and recombinant human IGF-1Albac, C. / Bartesaghi, R. / Créau, N. et al. | 2017
- S691
-
Transcutaneous vagus nerve stimulation for treatment-resistant depression – the first experiences: a pilot studyAntosik-Wójcińska, A.Z. / Kaczmarczyk, M. / Swięcicki, Ł. et al. | 2017
- S692
-
Altered functional connectivity of the amygdala during humor processing in patients with schizophreniaBerger, P. / Bitsch, F. / Nagels, A. et al. | 2017
- S693
-
Treatment-resistant depression in schizophrenia: clinical response predictors of repetitive transcranial magnetic stimulation (rTMS)Maslenikov, N. / Tsukarzi, E.E. / Mosolov, S.N. et al. | 2017
- S695
-
Social cognition in schizophrenia patients and their siblings: the role of insulaCaldiroli, A. / Buoli, M. / Van Haren, N. et al. | 2017
- S696
-
Increased glutamate/GABA ratio links the autism and schizophrenia spectra through a social disorganisation trait phenotypeFord, T.C. / Nibbs, R. / Crewther, D.P. et al. | 2017
- S697
-
Correlation between depression and volume of hippocampal subfields in the elderly with subclinical depressionKim, S.K. / Lee, J.G. et al. | 2017
- S698
-
Glutamate levels in the medial prefrontal cortex during pregnancyLe Melledo, J.M. / Ghuman, A. / McEwen, A. et al. | 2017
- S700
-
Superficial white matter integrity in autism spectrum disordersD'Albis, M.A. / Guevara, P. / Guevara, M. et al. | 2017
- S701
-
White matter connectivity related to amisulpride treatment response in patients with schizophreniaKim, J.H. / Choi, T.K. / Lee, S.H. et al. | 2017
- S702
-
Deviations from the physiological, ultradian glucocorticoid rhythm are accompanied by altered behavioural and fMRI responses to emotional stimulationKalafatakis, K. / Russell, G.M. / Harmer, C.J. et al. | 2017
- S703
-
High angular resolution diffusion imaging correlates of depression in Parkinson's disease: a connectometry studyMayeli, M. / Sobhani, S. / Ghazi Sherbaf, F. et al. | 2017
- S704
-
Effects of natural medicinal on emotional brain responseColic, L. / Martens, L. / Fensky, L. et al. | 2017
- S705
-
Effects of natural medicinal on amygdala-centered resting state functional connectivityColic, L. / Fan, Y. / Fensky, L. et al. | 2017
- S706
-
Meditation-associated change in the functional connectivity of the insulaJang, J.H. / Kim, J.H. / Yun, J.Y. et al. | 2017
- S707
-
Non-invasive magnetic resonance imaging of human serotonin function: dose-dependent effects of citalopramSchrantee, A. / Lucassen, P. / Booij, J. et al. | 2017
- S708
-
Monoamine oxidase A distribution volume as a correlate for electroconvulsive therapy – preliminary resultsBaldinger-Melich, P. / James, G.M. / Gryglewski, G. et al. | 2017
- S709
-
Tryptophan catabolism affects the neural correlates of mood-congruent processing biases in bipolar depressionVai, B. / Riberto, M. / Ghiglino, D. et al. | 2017
- S710
-
Investigation of cerebral cortex hemodynamic activations using fNIRS during mind reading task in subjects with autism spectrum disorderDuman, B. / Kale, E. / Yenihayat, I. et al. | 2017
- S711
-
Brain responses in the theory of mind network are modulated by intention type in schizophreniaBitsch, F. / Berger, P. / Nagels, A. et al. | 2017
- S712
-
Assessment of the myelination of brain structures in patients with schizophrenia using the MRI methodParshukova, D. / Smirnova, L.P. / Seregin, A.A. et al. | 2017
- S713
-
Do metabolic parameters of posterior cingulate gyrus in multiple sclerosis correlate with the duration of the disease?Zacharzewska-Gondek, A. / Gondek, T.M. / Pokryszko-Dragan, A. et al. | 2017
- S715
-
Novel insights into the neurometabolic homeostasis of cocaine addiction: aberrant glutamatergic mechanisms in the nucleus accumbensEngeli, E. / Hock, A. / Zoelch, N. et al. | 2017
- S716
-
A multicenter positron emission tomography study of GABA receptor availability in adults with autismAndersson, M. / Horder, J. / Mendez, M. et al. | 2017
- S717
-
Evolution of default-mode network alteration in OCD-patients following a cognitive behavioral therapyTezenas, C. / Morgièvre, M. / Mallet, L. et al. | 2017
- S718
-
A novel social perception task for testing the social interaction model in pharmaco-fMRI protocols with selective serotonin reuptake inhibitorsBeinhölzl, N. / Naor, N. / Okon-Singer, H. et al. | 2017
- S719
-
Reduced gray matter in subcortical brain regions in MDD: preliminary results of an ultra-high field 7 Tesla MRI StudyVanicek, T. / Seiger, R. / Auer, B. et al. | 2017
- S720
-
Effects of cardiovascular fitness on hippocampal volume and vasculature in young adultsKaiser, A. / Schrantee, A. / Solleveld, M.M. et al. | 2017
- S721
-
Does brain magnetic resonance spectroscopy allow the detection of metabolite changes during immunomodulatory therapy in multiple sclerosis?Gondek, T.M. / Zacharzewska-Gondek, A. / Pokryszko-Dragan, A. et al. | 2017
- S722
-
Response inhibition in misophoniaEijsker, N. / Schröder, A. / Van Wingen, G. et al. | 2017
- S723
-
Hormone and menstrual cycle effects on sleep spindle parameters in oral contraceptive users and controlsUjma, P. / Kristóf, E. / Bódizs, R. et al. | 2017
- S724
-
Etanercept treatment reverses the impaired spatial and emotional memory functions in different age groups of genetic absence epileptic WAG/Rij ratsUtkan, T. / Demirtaş Şahin, T. / Karson, A. et al. | 2017
- S726
-
Examining cognition across the bipolar/schizophrenia diagnostic spectrumLynham, A.J. / Hubbard, L. / Tansey, K.E. et al. | 2017
- S727
-
Modulation of spatial memory function by the basal forebrain GABAergic neuronsKruashvili, L. / Burjanadze, M. / Chighladze, M. et al. | 2017
- S728
-
Changes in EEG markers by TAK-063 in subjects with stable schizophrenia have different temporal relationships with changes in working memoryMacek, T.A. / McCue, M. / Xie, J. et al. | 2017
- S729
-
Cognitive functions and signs of leptin resistance in patients with cerebrovascular disease and metabolic syndrome comorbidityKopchak, O. et al. | 2017
- S730
-
Pharmacological inhibition of bone resorption induces cognitive impairment in rats on high fat high fructose diet: metabolic correlationsZhelyazkova-Savova, M. / Gancheva, S. et al. | 2017
- S731
-
Neurocognitive functions in remission vs. psychotic states: a comparative study between bipolar disorder and schizophreniaCeylan, D. / Akdede, B.B. / Bora, E. et al. | 2017
- S732
-
Psychological and neural mechanisms of rotating leadership in teams: the impact of engagement and shared mental modelCasas Klett, T. / Ni, R. et al. | 2017
- S733
-
Social-intellectual deprivation effects on prefrontal cortex functioning and the "Theory of Mind" development – study in GeorgiaMetreveli, M. / Gagoshidze, T. et al. | 2017
- S734
-
Association of sleep quality and neurocognitive dysfunction in patients with depressionBerdzenishvili, E. / Tabagua, S. et al. | 2017
- S736
-
Effects of donepezil on scopolamine-induced cognitive impairment and Alzheimer's disease-like change in quantitative EEG analysis in rhesus monkeysNakako, T. / Iwamura, Y. / Matsumoto, A. et al. | 2017
- S737
-
Personality, stress, and multitaskingVan Schrojenstein Lantman, M. / Hoebregts, V. / Mackus, M. et al. | 2017
- S739
-
Probing translation: investigating the effect of a serotonin 5-HT6 antagonist compound on cognitive performance of aged ratsGyertyán, I. / Ernyei, A.J. / Kozma, K. et al. | 2017
- S740
-
A comparison of assessment of cognitive functioning on phones and tabletsVan de Loo, A.J.A.E. / Jansen, J. / Tiplady, B. et al. | 2017
- S741
-
Social cognition in autism spectrum disorder is associated with brain serotonin transporter availabilityTangen, A. / Andersson, M. / Nyström, K. et al. | 2017
- S742
-
Risk factor gene BIN1 induces late onset Alzheimer disease presymptomatic phenotypes in a BAC transgenic mouse modelMarechal, D. / Daudin, R. / Bourg, N. et al. | 2017
- S743
-
Rapid memory replay of life-like episodic sequence of events precedes their verbal recall from long-term memoryViñals, X. / Rodríguez, I. / Sols-Balcells, I. et al. | 2017
- S744
-
Risk factors for suicide in the late-life depression: age and sex-related differencesKim, J.W. / Lee, Y.S. et al. | 2017
- S746
-
Related factors with patients who didn't come to visits after being referred by primary careMata Sáenz, B. / Muñoz Martinez, V. / Nuevo Fernández, L. et al. | 2017
- S747
-
Prevalence and characteristics of schizophrenia in 1st versus 2nd generation East-African immigrants in Israel – a 30-year retrospective studyEger, G. / Reuven, Y. / Dreiher, J. et al. | 2017
- S748
-
Age-related pharmacotherapy of attention deficit hyperactivity disorder in adults in Slovenia from 2003 to 2015: a population-based studyStuhec, M. / Locatelli, I. et al. | 2017
- S749
-
Comparison of clinical characteristics between single and repeated suicide attempters admitted to emergency roomWon, S. / Lee, S.J. / Chang, S.M. et al. | 2017
- S750
-
Population and socioeconomic factor based assessment of postpartum depression risk in EuropeBaughman, C. / Bonthapally, V. / Arnold, R. et al. | 2017
- S751
-
Mirror-image study of aripiprazole long-acting injectable for the treatment of psychiatric patients attended in community mental health teamLeón Caballero, J. / Córcoles, D. / Gómez-Perez, L. et al. | 2017
- S752
-
Prenatal and postnatal maternal somatic anxiety and hyperactivity symptoms in childrenBolea-Alamanac, B. / Davies, S. et al. | 2017
- S753
-
Low range magnetic field reduces anxiety degree in genetically epilepsy-prone ratsBukia, N. / Kekelia, G. / Butskhrikidze, M. et al. | 2017
- S754
-
Neuropeptide Y and calcitonin gene-related peptide in CSF in Parkinson's disease with comorbid depression versus major depressive disorderMathé, A.A. / Pâlhagen, S. / Svenningsson, P. et al. | 2017
- S755
-
A study of uric acid concentration in bipolar disorder and schizophreniaMalewska, M. / Permoda-Osip, A. / Szeliga-Neyman, A. et al. | 2017
- S756
-
AMPA receptor subunit expression and receptor binding in patients with addiction: a systematic review of postmortem studiesUeno, F. / Matsushita, S. / Tsujii, T. et al. | 2017
- S758
-
Early life stress affects glutamatergic postsynaptic density genes: implications for novel treatment targetsBuonaguro, E.F. / Morley-Fletcher, S. / Avagliano, C. et al. | 2017
- S759
-
The association between suicide attempts and Toxoplasma gondii infectionShim, S. / Jung, H. / Yang, J. et al. | 2017
- S760
-
The role of C1473G polymorphism in mouse tryptophan hydroxylase-2 gene in the response of brain serotonergic system and behavior to short photoperiodBazhenova, E.Y. / Khotskin, N.V. / Sorokin, I.E. et al. | 2017
- S761
-
Relationship between hippocampal subfield volumes and cortisol awakening response parameters in major depressive disorderDoolin, K. / Frodl, T. / O'Keane, V. et al. | 2017
- S762
-
Clinical characterisation of neurexin1 deletions and their role in neurodevelopmental disordersFitzgerald, J. / Al-Shehhi, M. / Lynch, S. et al. | 2017
- S764
-
Learning deficits and hippocampal neurogenesis in rats overexpressing the dopamine transporterBernhardt, N. / Lieser, M. / Edemann Callesen, H. et al. | 2017
- S765
-
Chronic magnesium supplementation increases hippocampal neurogenesis and decreases proliferation in myocardium in ACTH-treated ratsPetrovic, J. / Labudović-Borović, M. / Puškaš, N. et al. | 2017
- S766
-
Ghrelin: a potential role in the physiological adaptations to long term food restriction and nutritional recovery?Duriez, P. / Berreby, E. / Tolle, V. et al. | 2017
- S767
-
Metabolic, endocrine and central alterations in a chronic mouse model of food restrictionMequinion, M. / Duriez, P. / Le Thuc, O. et al. | 2017
- S768
-
Evaluation of the activity of bupropion in a mouse model of posttraumatic stress disorder using forced swim and elevated plus maze testsMalikowska, N. / Sałat, K. et al. | 2017
- S769
-
NS-398 potentiates the antidepressant-like effect of MTEP in mice: involvement of pro-inflammatory cytokine pathways in the brainSowa-Kućma, M. / Misztak, P. / Pańczyszyn-Trzewik, P. et al. | 2017
- S771
-
Behavioral and hormonal effects of vitamin D3 hormone treatment in the adult female rats with experimental model of menopauseFedotova, J. / Pivina, S.G. / Suchko, A.V. et al. | 2017
- S772
-
Mood disorders in the offspring of antenatally depressed mothers in the Northern Finland 1966 Birth Cohort: relationship to parental mental disorderTaka-Eilola, T. / Mäki, P. / Veijola, J. et al. | 2017
- S773
-
Synapse numbers in the infralimbic cortex of rats subjected to long-term stressCsabai, D. / Wiborg, O. / Czéh, B. et al. | 2017
- S774
-
Effect of mTOR silencing in mouse infralimbic cortex on depressive-like behaviourGarro-Martinez, E. / Fullana, N. / Paz, V. et al. | 2017
- S775
-
Autophagy and affective disorders: pharmacological and molecular studiesKara, N. / Luczak, T. / Agam, G. et al. | 2017
- S776
-
Altered hippocampal proteins in depressive-like rats after chronic stress: findings from a proteomic studyLi, X. / Zhang, Z. / Reynolds, G.P. et al. | 2017
- S777
-
Regulation of cannabinoid CB1 and CB2 receptors and neuroprotective rapamycin (mTOR protein kinase) in major depression postmortem brainsSalort, G. / Hernández-Hernández, E. / García-Fuster, M.J. et al. | 2017
- S778
-
Attentional processing of emotional information in remitted recurrent major depressive disorder – preliminary results from the NEWPRIDE studyVan Kleef, R.S. / Nijmeijer, S.E. / Marsman, J.B.C. et al. | 2017
- S779
-
Heart rate variability, autonomic tone and depressive-like behavior differences in resilient and susceptible rats to social defeat stressMorais-Silva, G. / Costa-Ferreira, W. / Gomes-de-Souza, L. et al. | 2017
- S780
-
3β Methoxypregnenolone (MAP4343), a synthetic pregnenolone derivative, promotes neuronal and synaptic plasticity in vitroSchverer, M. / Leandri, J. / Amazit, L. et al. | 2017
- S781
-
The microtubule associated protein tau is essential for stress-driven depressive pathology and cognitive deficitsVaz-Silva, J. / Lopes, S. / Dioli, C. et al. | 2017
- S782
-
Cell-specific immune regulation and metabolic dysfunction in major depressive disorderHasselmann, H. / Taenzer, A. / Gamradt, S. et al. | 2017
- S783
-
Anti-depressant-like effects of cannabidiol and cannabidiolic acid in genetic rat models of depressionShbiro, L. / Hen-Shoval, D. / Hazut, N. et al. | 2017
- S784
-
Pharmacological prophylaxis of postpartum exacerbation in depressive and anxiety symptoms: a retrospective chart reviewUguz, F. / Subasi, E. / Dalboy, F. et al. | 2017
- S786
-
Toward a better characterisation and management of treatment-resistant depression in France through the network of expert centers (FondaMental)Yrondi, A. / El-Hage, W. / Charpeaud, T. et al. | 2017
- S787
-
The role of rare copy number variants in depressionKendall, K. / Rees, E. / Jones, I. et al. | 2017
- S788
-
Effect of agomelatine and escitalopram on emotional experiences in outpatients suffering from major depressive disorderGoodwin, G. / Scott, E. / Reis De Oliveira, I. et al. | 2017
- S789
-
Association of depression with the 10-year risk of cardiovascular mortality in primary care population in LatviaIvanovs, R. / Kivite, A. / Mintale, I. et al. | 2017
- S790
-
Depression-Associated Cardiac Failure (DACFAIL)Menke, A. / Wurst, C. / Stonawski, S. et al. | 2017
- S792
-
Cannabis use among depressive people: a study about one hundred thirty-six outpatientsAmamou, B. / Fathallah, S. / Mhalla, A. et al. | 2017
- S793
-
GSK-3beta rs334558 is associated with severe insomnia in patients with major depressive episode, but not with remission after antidepressant treatmentCostemale-Lacoste, J.F. / El Asmar, K. / Colle, R. et al. | 2017
- S794
-
Cognitive performance in patients with major depressive disorder treated with vortioxetine compared with escitalopram and venlafaxineFernandez-Miranda, J.J. / Frias-Ortiz, D.F. / Diaz-Fernandez, S. et al. | 2017
- S795
-
Cognitive performance and 12-month clinical outcome in first-episode of depressionVicent-Gil, M. / Keymer-Gausset, A. / Carceller-Sindreu, M. et al. | 2017
- S796
-
A meta-analysis of dose escalation of antidepressant agents in major depressive disorderBartova, L. / Dold, M. / Rupprecht, R. et al. | 2017
- S797
-
Effects of vortioxetine on composite scores across objective cognitive tests: results from 2 clinical studies in adults with major depressive disorderLoft, H. / Jacobson, W. / Olsen, C.K. et al. | 2017
- S798
-
Cognition predicts psychosocial functioning and psychological treatment adherence in depressive disordersCostas, A. / Ramos Grille, I. / Garrido García, G. et al. | 2017
- S799
-
The relation between major depressive disorder and comorbid generalized anxiety disorder – results from a European multicenter, cross-sectional surveyDold, M. / Bartova, L. / Souery, D. et al. | 2017
- S800
-
Gene polymorphisms of enzymes biotransformation of xenobiotics in patients with depressive disordersLevchuk, L. / Losenkov, I.S. / Lebedeva, E.V. et al. | 2017
- S801
-
Cortical monoamine oxidase – a distribution in seasonal affective disorder compared to healthy controlsJames, G.M. / Seiger, R. / Spies, M. et al. | 2017
- S803
-
The relationship between chronotype and problematic drinking according to gender in mood disorderKong, J.Y. et al. | 2017
- S804
-
Early screening during pregnancy for maternal psychopathology reduced postpartum depressive symptoms and improved mother-infant attachmentPetri, E. / Bacci, O. / Palagini, L. et al. | 2017
- S805
-
Dynamic connectivity analysis of selective serotonin reuptake inhibitor effects, a pharmacological PET/MR studyGryglewski, G. / Hahn, A. / Berroterán-Infante, N. et al. | 2017
- S807
-
Efficacy of venlafaxine extended-release compared with placebo in major depressive disorder patients by severity of anxiety symptomsLyndon, G. / Prieto, R. / Wajsbrot, D. et al. | 2017
- S808
-
A real-world study on time-to-initiation and dose optimization of major depressive disorder treatment in the United StatesPrieto Lopez, R. / Yeh, Y. / Gao, X. et al. | 2017
- S809
-
Sleep quality in mothers with postpartum depression and maternity blues: a preliminary studyDel Matto, L. / Costoloni, G. / Caterini, C. et al. | 2017
- S811
-
Time perception and binge watching among medical students with depressive symptomsBoudali, M. / Hamza, M. / Halayem, S. et al. | 2017
- S812
-
Adjunctive antidepressants to mood stabilizers or atypical antipsychotics in bipolar depression and 1-year rehospitalization rates: a cohort studyShvartzman, Y. / Krivoy, A. / Valevski, A. et al. | 2017
- S814
-
Structural brain differences between psychotic and non-psychotic bipolar patientsEsposito, C.M. / Fumagalli, G. / Lanfranconi, S. et al. | 2017
- S815
-
Social cognition in bipolar disorder: exploring emotional intelligenceVaro, C. / Jimenez, E. / Solé, B. et al. | 2017
- S816
-
Bipolar type I and substance use disorders: safety, tolerability and effectiveness of asenapine adjunctive treatmentFernandez-Miranda, J.J. / Frias-Ortiz, D.F. / Diaz-Fernandez, S. et al. | 2017
- S817
-
Body mass index associates with measures of white matter integrity in bipolar disorderMazza, E. / Poletti, S. / Bolletini, I. et al. | 2017
- S818
-
Atherogenic index of plasma in manic, depressive and euthymic stages of bipolar disorderKaramustafalioglu, N. / Kalelioglu, T. / Unalan, P. et al. | 2017
- S819
-
Could lithium prevent the bipolar disorder brain atrophy?Hozer, F. / Sarrazin, S. / Mangin, J.F. et al. | 2017
- S820
-
The brain-gut axis profiles in patients with bipolar depression: a preliminary studyHu, S. / Lu, Q. / Lai, J. et al. | 2017
- S821
-
Neurotrophins, inflammation and oxidative damage as mediators of cognitive functioning in bipolar disorderMora, E. / Portella, M. / Pinol-Ripoll, G. et al. | 2017
- S822
-
Predicting functional impairment in bipolar disorder: a pilot study with a machine learning approachPinto, J.V. / Librenza-Garcia, D. / Baldez, D.P. et al. | 2017
- S823
-
Antipsychotic use in acute mania: a retrospective study in an affective disorder specialized unit in Lisbon, PortugalCoelho, I. / Gonçalves, F. / Aleixo, A. et al. | 2017
- S824
-
Benefits and harms of atypical antipsychotics in the treatment of bipolar depression: a systematic review and metaanalysisNosaka, T. / Hagi, K. / Pikalov, A. et al. | 2017
- S825
-
Lurasidone adjunctive to lithium or valproate in patients with bipolar I disorder: effectiveness of up to 20 weeks of treatmentPikalov, A. / Tsai, J. / Mao, Y. et al. | 2017
- S826
-
One-year course of illness and clinical management in a cohort of patients affected with schizoaffective and bipolar disordersMurru, A. / Verdolini, N. / Pacchiarotti, I. et al. | 2017
- S827
-
IL-6 levels in bipolar patients with manic episodeTorres-Suarez, T. / Ramirez-Bermudez, J. / Diaz, A. et al. | 2017
- S828
-
Recurrence and recovery in aripiprazole once-monthly maintenance treatment of bipolar I disorder: a blinded, placebo-controlled, randomised studySuch, P. / Calabrese, J.R. / Sanchez, R. et al. | 2017
- S829
-
Graph analysis of verbal fluency test discriminates between patients with bipolar disorder and healthy controlsMachalska, K. / Turek, A. / Chrobak, A.A. et al. | 2017
- S830
-
High prevalence of cesarean sections in women with bipolar disorderSolé, E. / Suárez-Jesús, J. / Torres, A. et al. | 2017
- S831
-
Lurasidone for the treatment of major depressive disorder with mixed features: do manic symptoms moderate treatment response?Pikalov, A. / Goldberg, J. / Siu, C. et al. | 2017
- S832
-
Possible links between antipsychotic dosage equivalency and clinical features in bipolar patientsNascimento, M. / Bacelar, F. / Nobre, A. et al. | 2017
- S833
-
Functional impairment in adult bipolar disorder with ADHDTorres, I. / Garriga, M. / Sole, B. et al. | 2017
- S834
-
Tract-based fractional anisotropy mediates the relationship between illness duration and cognitive performances in bipolar disorderMelloni, E.M.T. / Poletti, S. / Bollettini, I. et al. | 2017
- S835
-
The serum S100B as a potential marker in bipolar spectrum disorderKapelski, P. / Rajewska-Rager, A. / Dmitrzak-Weglarz, M. et al. | 2017
- S836
-
Potential genes behind the difference between bipolar I and bipolar II disorderShugol, M. / Popovic, D. / Fabbri, C. et al. | 2017
- S837
-
The impact of psycho-educational group program on drug attitude and global functioning of real patients with bipolar disorderAlba, L. / Pérez, E.J. / Santamaria, M. et al. | 2017
- S838
-
Predominant polarity in bipolar disorder – is there a genetic base?Popovic, D. / Sentissi, O. / Stukalina, Y. et al. | 2017
- S839
-
Bipolar disorder and white matter microstructure: ENIGMA bipolar disorder fractional anisotropy DTI resultsPauling, M. / Henry, C. / Sarrazin, S. et al. | 2017
- S840
-
The efficacy of vortioxetine in a major depression case and follow-up of pruritus adverse effectYelken, B. et al. | 2017
- S841
-
Methodological limitations of comparative effectiveness research on antidepressants: a simulation studyChevance, A. / Naudet, F. / Gaillard, R. et al. | 2017
- S843
-
Chronic stress exposure impairs GABAergic homeostasis in the hippocampus: restorative effect of the novel antipsychotic lurasidoneRiva, M.A. / Rossetti, A. / Paladini, M.S. et al. | 2017
- S844
-
Evaluation of inhaled loxapine treatment in psychiatric patients with acute agitationMendez Mareque, D.R. / Aller Labandeira, V. / Lopez Cortiña, A. et al. | 2017
- S845
-
The role of the combined treatment of fluoxetine and metformin in potentiating antidepressant efficacyPoggini, S. / Viglione, A. / Matte Bon, G. et al. | 2017
- S846
-
Sex differences should be considered in the administration of lithium carbonate to patients with metabolic syndromeYonezawa, H. / Nagamine, T. / Nakamura, K. et al. | 2017
- S847
-
Effectiveness and tolerability of vortioxetine for major depressive disorderRomero Guillena, S.L. / Plasencia Garcia de Diego, B.O. / Navarro, R. et al. | 2017
- S848
-
Sleep deprivation with sleep phase advance in treatment-resistant depression: biological features of efficacyDopierala, E. / Jasmska-Mikołajczyk, A. / Ferensztajn-Rochowiak, E. et al. | 2017
- S849
-
The impact of currently recommended antihypertensive therapy on depression and other psychometric parameters: a prospective pilot studyKorosi, B. / Laszlo, A. / Tabak, A. et al. | 2017
- S850
-
Use of benzodiazepines in relation to onset and duration of untreated illness in psychotic and affective disordersDe Carlo, V. / Grancini, B. / Vismara, M. et al. | 2017
- S851
-
Quetiapine – adjunctive treatment of major depressive disorder with anxiety symptomsBise, S. / Sulejmanpašić, G. / Begic, D. et al. | 2017
- S853
-
Efficacy of dialectical behavior therapy compared to supportive therapy in adolescents with suicidal behaviorSantamarina Pérez, P. / Romero Cela, S. / Méndez Blanco, I. et al. | 2017
- S854
-
Effectiveness of inhaled loxapine (IL) in agitated patients diagnosed with personality disorder (PD) – a first approachPatrizi, B. / Navarro Haro, M.V. / Gasol, M. et al. | 2017
- S855
-
Pharmacological treatments and risk of re-hospitalisation due to unipolar depression in a nationwide cohort of 123, 712 patientsTiihonen, J. / Tanskanen, A. / Hoti, F. et al. | 2017
- S856
-
SAGE-217 in subjects with major depressive disorder: efficacy and safety results from open-label Part A of a phase 2A studyGunduz-Bruce, H. / Riesenberg, R. / Sankoh, A. et al. | 2017
- S857
-
Intravenous sodium valproate for the treatment of mixed symptoms in patients with bipolar disorder: a pilot studyAmodeo, G. / Olivola, M. / Fagiolini, A. et al. | 2017
- S858
-
Could cognitive remediation therapy increase psychological treatment adherence in depression disorders? The role of cognitive impairment (pilot study)Costas, A. / Ramos Grille, I. / Garrido García, G. et al. | 2017
- S859
-
Escitalopram versus duloxetine in acute treatment of major depressive disorder: a meta-analysis and systematic reviewManeeton, B. / Maneeton, N. / Woottiluk, P. et al. | 2017
- S860
-
Switching to vortioxetine from a selective serotonin reuptake inhibitor in patients with major depression in remission: focus on tolerabilityScarpellini, P. / Cerù, A. et al. | 2017
- S861
-
Intravenous clomipramine for treatment resistant depressionTrusso, M.A. / Baldini, I. / Fagiolini, A. et al. | 2017
- S862
-
Sex and interaction of CYP1A2 *1F/*1F genotype with smoking impact mirtazapine pharmacokinetics: a population pharmacokinetic analysisMadia, P. / Bies, R. / Pollock, B. et al. | 2017
- S863
-
Efficacy, safety, and tolerability of vortioxetine in the treatment of mood disordersTomassini, L. / Perrini, F. / Cuomo, I. et al. | 2017
- S865
-
Effects of adjunctive aripiprazole in patients with major depressive disorder with inadequate response to standard antidepressant therapyLee, J.S. / Kim, S.G. et al. | 2017
- S866
-
Safety and efficacy of ketamine infusion in treatment-resistant depression with multiple medical comorbidities: a case reportNakahira, C. / Steglich, M.S. / Ferreira, M.B. et al. | 2017
- S867
-
Effect of long-term valproate treatment on bone metabolism in patients with bipolar disorder: a pilot studyCuomo, A. / Costoloni, G. / Goracci, A. et al. | 2017
- S868
-
SSRI outcome depends on the environment: citalopram amplifies the influence of sociodemographic characteristics on mood in the STAR*D studyViglione, A. / Poggini, S. / Matte Bon, G. et al. | 2017
- S869
-
Net effect of serotonin reuptake inhibitors on suicidality in depression is beneficial rather than harmful already during the first week of treatmentNäslund, J. / Hieronymus, F. / Lisinski, A. et al. | 2017
- S870
-
Do SSRIs cause an initial increase in anxiety in depressed patients participating in placebo-controlled trials?Näslund, J. / Hieronymus, F. / Emilsson, J.F. et al. | 2017
- S871
-
Longitudinal investigation of subjective and objective cognitive side effects of electroconvulsive therapy – a pilot studyPetersen, J.Z. / Jørgensen, M.B. / Jensen, H.M. et al. | 2017
- S872
-
Comorbidity of depression and panic disorder affects suicide attempts in patients with mood disordersLiaugaudaite, V. / Podlipskyte, A. / Mickuviene, N. et al. | 2017
- S873
-
Clinical and genetic risk factors associated with suicidality in Korean patients with mood disordersKim, S.I. / Choi, H.Y. / Lim, W.J. et al. | 2017
- S874
-
Theory of mind and depersonalization in borderline personality disorderRomero Guillena, S.L. / Gotor Sanchez-Luengo, F. / Plasencia Garcia de Diego, B.O. et al. | 2017
- S875
-
Suicide ideation, anger and impulsiveness in chronic pain patients before and after pain relief: an observational studyMancini, V. / Marini, S. / Lalli, V. et al. | 2017
- S876
-
Is aggression a missed bipolar diagnostic feature in mixed depression?Verdolini, N. / Perugi, G. / Samalin, L. et al. | 2017
- S877
-
Effects of lithium on metabolic parameters and clinical response: a retrospective analysis of 820 mood disorder patientsPinna, M. / Manchia, M. / Visioli, C. et al. | 2017
- S878
-
Mania associated with digoxin: case description and literature reviewZuñiga-Costa, R. / Yelmo-Cruz, S. / Diaz-Melian, D. et al. | 2017
- S879
-
Mediterranean diet and moodDe Vries, E. / Van Schrojenstein Lantman, M. / Hoebregts, V. et al. | 2017
- S881
-
Toxoplasma gondii seroprevalence in a cohort of Italian psychiatric inpatients with mood or psychotic disorders: a preliminary communicationDel Grande, C. / Schiavi, E. / Masci, I. et al. | 2017
- S882
-
Depression symptoms and obstructive sleep apnea in coronary artery disease patientsJuskiene, A. / Varoneckas, G. / Podlipskyte, A. et al. | 2017
- S883
-
Depressive symptoms in elderly indigenous people of the Xukuru do Ororuba ethinic group, BrazilPetribu, K. / Lima, F. / Brotto, S. et al. | 2017
- S885
-
Polygenic risk profile score increases schizophrenia liability mostly through cognition pathways: mathematical causation models with polygenic riskToulopoulou, T. / Zhang, X. / Cherny, S. et al. | 2017
- S886
-
Abnormal visual scanning during reality evaluation and its relationship to magical ideation in schizophreniaLee, J.S. / Kim, M.W. / Kim, J.J. et al. | 2017
- S887
-
Disrupting protein-protein interactions of neuronal nitric oxide synthase: implications in schizophrenia-related behavioursCandemir, E. / Fattakhov, N. / Frerichs, V. et al. | 2017
- S888
-
Enhanced evaluative fear learning in delusion-pronenessLouzolo, A. / Ingvar, M. / Olsson, A. et al. | 2017
- S889
-
The effect of genetic variant of the ANKK1 gene with cannabis misuse in incipient psychotic patients: a controlled studySanchez-Gistau, V. / Arranz, S. / Sole, M. et al. | 2017
- S890
-
Sex differences in a neurodevelopmental animal model of schizophrenia: focus on white matter structures and myelinStark, T. / Drazanova, E. / Vaskovicova, N. et al. | 2017
- S891
-
Lactational immune activation model: from trans-diagnostic risk to trans-diagnostic preventionArad, M. / Piontkewitz, Y. / Albelda, N. et al. | 2017
- S892
-
Maintenance to win: prospective observational study of extended-release injectable aripiprazole for maintenance therapy in psychotic outpatientsDe La Gandara, J.J. / Mayo, S. et al. | 2017
- S893
-
The effects of nutriose-glucomannan-antioxidant complex on the parameters of the metabolic syndrome in the schizophrenia patients treated with olanzapineDjokic, G.M. / Djordjevic, V. / Agic, A. et al. | 2017
- S894
-
Blood biomarkers predict the cognitive effects of aripiprazole in patients with acute schizophreniaHori, H.H. / Yoshimura, R.Y. / Katsuki, A.K. et al. | 2017
- S896
-
Schizophrenia and adjunctive aripiprazole for antipsychotic-induced sexual dysfunctionSulejmanpasic-Arslanagic, G. / Bise, S. et al. | 2017
- S897
-
Cognitive effects of polypharmacy in psychotic disorders – less is moreAndric Petrovic, S. / Jerotic, S. / Ristic, I. et al. | 2017
- S898
-
A systematic review of methods for the assessment of antipsychotics adherence: focus on delusional disorderGonzalez Rodriguez, A. / Estrada, F. / Monreal, J.A. et al. | 2017
- S899
-
The association between serum levels of brain-derived neurotrophic factor and cognitive impairment in chronic elderly schizophrenia inpatientsAtake, K. / Nakamurra, T. / Ueda, N. et al. | 2017
- S900
-
Early-onset inguinal hernia as risk factor for schizophrenia or related psychosis: a nationwide register-based cohort studyMelkersson, K. / Wernroth, L. et al. | 2017
- S901
-
Electrophysiological and neurocognitive correlates of the disorganization factor in schizophreniaVignapiano, A. / Koenig, T. / Mucci, A. et al. | 2017
- S902
-
Cariprazine vs risperidone efficacy on predominant negative symptoms of schizophrenia: post hoc analysis of negative symptoms subdomainsLaszlovszky, I. / Barabassy, A. / Szatmári, B. et al. | 2017
- S903
-
Demographic and pharmacological profile of inpatients treated with intramuscular paliperidone palmitate in a psychiatric unitGonzález Garrido, S. / Riesgo Arias, M. / Banda Moruno, J. et al. | 2017
- S904
-
Non organic hallucinatory behaviour and neurocognitive deterioration in patients with functional psychosesOlteanu, V.A. / Dehelean, L. / Romosan, A. et al. | 2017
- S905
-
Risk factors for low bone mineral density in patients taking antipsychotics for psychosisYoo, T. / Kim, S.W. / Jhon, M. et al. | 2017
- S907
-
Evaluation of olfactory function in patients with recent onset psychosis and at-risk mental state in an early intervention programArranz, S. / Izquierdo, E. / Cabezas, A. et al. | 2017
- S908
-
Healthcare resource use in schizophrenia sufferers – findings from the EuroSC cohortMillier, A. / Toumi, M. / Horváth, M. et al. | 2017
- S909
-
Health-related quality of life in outpatients with schizophrenia: what determines changes over time and how to measure themDomenech, C. / Altamura, C. / Bernasconi, C. et al. | 2017
- S910
-
Hand functions in patients with schizophrenia: comparison with bipolar disorder and healthy subjectsHacioglu Yildirim, M. / Yildirim, E.A. / Carpar, E. et al. | 2017
- S911
-
Obstetric complications and cognitive function in schizophreniaMezquida, G. / Fernandez-Egea, E. / Treen, D. et al. | 2017
- S913
-
Two-year follow-up of patients with a first psychotic episode: comparison between affective and non-affective psychoses and predictors of functioningTorrent, C. / Reinares, M. / Martinez-Aran, A. et al. | 2017
- S914
-
Speech graph analysis of verbal fluency tests distinguish between patients with schizophrenia and healthy controlsTurek, A. / Machalska, K. / Chrobak, A.A. et al. | 2017
- S915
-
Comparison of serum tumor necrosis factor-like weak inducer of apoptosis levels in patients with schizophrenia and healthy control subjectsOzkal, U. / Gultekin, G. / Incir, S. et al. | 2017
- S917
-
Validation of the international classification of functioning, disability and health core set for schizophrenia from the perspective of psychologistsNuño, L. / Barrios, M. / Rojo, E. et al. | 2017
- S918
-
Break and recovery points of fusion differentiate schizophrenia from bipolar disorder patientsChrobak, A. / Abramowicz, M. / Perdziak, M. et al. | 2017
- S919
-
CB1-5-HT2A heteromers and neurological soft signs in schizophrenia patients: human studies in pro-neurons of the olfactory epitheliumGalindo, L. / Robledo, P. / Moreno, E. et al. | 2017
- S920
-
Nicotinic alpha7 receptor agonist and modulators improved social but not sensorimotor deficits on subchronic MK-801 model of schizophrenia in ratsUnal, G. / Zortul, H. / Hazar-Yavuz, A. et al. | 2017
- S921
-
Nigella sativa extract improved sensorimotor gating deficit on acute ketamine model of schizophrenia in ratsUnal, G. / Keles, R. / Taskin, T. et al. | 2017
- S922
-
Pre-clinical evaluation of two novel benzamides, LB-102 and 103, for the treatment of schizophreniaNeill, J. / Grayson, B. / Podda, G. et al. | 2017
- S923
-
Association of polymorphism in the dopamine receptors and transporter genes with hyperprolactinemia in patients with schizophreniaOsmanova, D. / Boiko, A.S. / Fedorenko, O.Y. et al. | 2017
- S924
-
Long-term antipsychotic treatment and corpus callosum volume: an MRI study in patients with schizophreniaTrehout, M. / Leroux, E. / Delcroix, N. et al. | 2017
- S925
-
Modulation of sub-chronic ketamine-induced locomotor sensitisation by midbrain dopamine neuron firingKokkinou, M. / Irvine, E.E. / Bonsall, D.R. et al. | 2017
- S926
-
Evolution of patients with paranoid schizophrenia treated with paliperidone injectionNechita, P. / Craciun, G. / Nechita, D.C. et al. | 2017
- S927
-
Follow-up 30 cases of patients treated with aripiprazole depot along 18 months continuation or discontinuationDe Jaime Ruiz, P. et al. | 2017
- S928
-
Pharmacological management of antipsychotic-induced obesity – a systematic literature reviewVasile, D. / Vasiliu, O. / Fainarea, A.F. et al. | 2017
- S929
-
Aripiprazole once-monthly long-acting injectable in schizophreniaPlasencia García de Diego, B.O. / Romero Guillena, S.L. / Gotor Sanchez-Luengo, F. et al. | 2017
- S930
-
E-medicine: a smartphone application to antipsychotic switchBottaï, T. / Dassa, D. / Raymondet, P. et al. | 2017
- S931
-
Antipsychotic treatment in hospitalized patients with schizophrenia and with the occurence of aggressive behavior (2-years review)Zelman, M. / Godinova, S. / Zholob, M. et al. | 2017
- S932
-
Cariprazine specificity profile in the treatment of acute schizophrenia: a meta-analysis and meta-regression of randomized-controlled trialsCorponi, F. / Serretti, A. / Montgomery, S. et al. | 2017
- S933
-
Schizophrenia, hospitalisations and antipsychotic treatment: analysing LAI patterns in a brief hospitalisation unitPascual, J.M. / Mongil San Juan, J.M. / Rodriguez Gomez, C. et al. | 2017
- S934
-
Inflammatory processes and schizophrenia: evidence from a twin studyStassen, H.H. / Braun, S. / Bridler, R. et al. | 2017
- S935
-
Sustained remission with cariprazine treatment: post hoc analysis of a randomized, double-blind, schizophrenia relapse prevention trialCorrell, C.U. / Potkin, S.G. / Durgam, S. et al. | 2017
- S936
-
Efficacy of cariprazine in subgroups of bipolar patients with manic episodes, mixed episodes, and with or without psychotic symptomsVieta, E. / Durgam, S. / Lu, K. et al. | 2017
- S937
-
Antipsychotics and mortality in a nationwide cohort of 29, 823 patients with schizophreniaTiihonen, J. / Mittendorfer-Rutz, E. / Alexanderson, K. et al. | 2017
- S938
-
Long-term complex therapy of schizophrenia with paliperidone palmitate in combination with psychosocial interventions in outpatient settingsSavelyev, A. / Korman, T. / Gritsevskaya, T. et al. | 2017
- S940
-
The validity and sensitivity of PANSS-6 in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) studyOstergaard, S.D. / Foldager, L. / Mors, O. et al. | 2017
- S942
-
Sustained remission and symptom stability in patients with schizophrenia receiving aripiprazole once-monthly: a 52-week, open-label, maintenance studyPeters-Strickland, T. / Jin, N. / Such, P. et al. | 2017
- S943
-
Inflammatory markers and clinical outcome in treatment resistant schizophrenia inpatients treated with clozapineKalter, E. / Horovitz, T. / Shlosberg, D. et al. | 2017
- S944
-
Patient reported outcomes from schizophrenia patients treated with paliperidone palmitate 1-monthly for at least 6 months (picture study)Vega, M. / Arqués, S. / Herrera, B. et al. | 2017
- S945
-
Potential biomarkers of tardive dyskinesia: a multiplex analysis of blood serumBoiko, A.S. / Kornetova, E.G. / Ivanova, S.A. et al. | 2017
- S946
-
Antidepressant augmentation of antipsychotics in schizophrenia: a systematic review, meta-analysis and metaregression analysisGalling, B. / Correll, C.U. et al. | 2017
- S947
-
Evenamide, a voltage-gated sodium channel blocker in the treatment of schizophrenia: results from a placebo-controlled studyAnand, R. / Forrest, E.C. / Hartman, R.D. et al. | 2017
- S948
-
Deep brain stimulation in schizophrenia: a randomized pilot study testing anterior cingulated cortex vs. nucleus accumbens targetsRoldán, A. / Sarró, S. / Rabella, M. et al. | 2017
- S949
-
Redox dysregulation in schizophrenia pathophysiology: add-on trial with N-acetyl-cysteine (NAC) in early psychosis patientsFournier, M. / Conus, P. / Seidman, L. et al. | 2017
- S950
-
Subset analyses by race of a phase 2 study of TAK-063 in subjects with acute exacerbations of psychotic symptomsMahableshwarkar, A.R. / McCue, M. / Dong, X. et al. | 2017
- S951
-
Are there differences in the antipsychotic load between deficit and non-deficit syndrome in first-episode schizophrenia?López-Díaz, A. / Lara, I. / Lorenzo-Herrero, P. et al. | 2017
- S952
-
Aripiprazole LAI vs. paliperidone LAI in inpatients with psychosis comorbid with substance use disorder: clinical and QoL effects at 1-year follow-upCuomo, I. / Kotzalidis, G.D. / De Persis, S. et al. | 2017
- S953
-
Safety and tolerability of brexpiprazole in adults with schizophrenia: results of an open-label, long-term studyWeiss, C. / Forbes, A. / Hobart, M. et al. | 2017
- S954
-
Lifetime use of psychiatric medications and cognition at 43 years of age in schizophrenia in the Northern Finland Birth Cohort 1966Hulkko, A. / Murray, G.K. / Moilanen, J. et al. | 2017
- S955
-
Theta burst stimulation on medial prefrontal cortex in schizophrenia patients with impaired social cognition: a pilot 1H-MRS studyBriend, F. / Nathou, C. / Kauffmann, F. et al. | 2017
- S957
-
Effect of brexpiprazole on prolactin: an analysis of short- and long-term trials in schizophreniaIvkovic, J. / Lindsten, A. / George, V. et al. | 2017
- S958
-
Effect of dopamine D2 receptor and serotonin 2A receptor gene polymorphisms on response to risperidone in schizophreniaCharanraj Goud, A. / Shewade, D.G. / Raj Kumar, R. et al. | 2017
- S960
-
Hospitalisation rate in individuals with schizophrenia treated with long acting injectable atypical antipsychotics in Latin America – the REALAI studyRodriguez, R. / Palmeira, L. / Ramos, J. et al. | 2017
- S962
-
Effects of sertindole on EEG activity in patients with schizophreniaDebicka, M. / Kroc, A. / Wierzbicka, A. et al. | 2017
- S963
-
Effect of omega-3 supplementation during pregnancy and in offspring adolescence: an animal model of schizophrenia induced by poly(I:C)Rosa, E.D. / Géa, L.P. / Panizzutti, B.S. et al. | 2017
- S964
-
Proteomic profiling changes induced by physical activity in patients with schizophreniaVallejo-Curto, M. / Rivera-Baltanás, T. / Blanco-Formoso, M. et al. | 2017
- S965
-
The involvement of GABAB receptors in antipsychotic-like effects of positive allosteric modulator of muscarinic acetylcholine M4 receptorsCiešlik, P. / Woźniak, M. / Pilc, A. et al. | 2017
- S966
-
Does genetics of obesity overlap with pharmacogenetics of antipsychotic induced weight gain? A molecular pathway analysisCorfitsen, H. / Krantz, B. / Drago, A. et al. | 2017
- S967
-
Epigenetic signature of early trauma: differences in the FKBP5 DNA methylation levels among psychotic patients, their healthy siblings and controlsMihaljevic, M. / Franic, D. / Soldatovic, I. et al. | 2017
- S968
-
Compliance with psychotropic medications – a patient's perspectiveVidenova, V. / Manuseva, N. / Stefanovski, B. et al. | 2017
- S969
-
Factors predicting personal and social performance in patients with schizophreniaKim, S.H. / Yi, J.S. / Kim, J.J. et al. | 2017
- S970
-
Sleep disturbance in schizophrenia inpatients and related factorsKim, S.K. / Jung, B.J. et al. | 2017
- S971
-
The report on current state and effectiveness of occupational therapy with mentally disabled people in KoreaLee, S.M. / Chung, H.Y. / Hong, M. et al. | 2017
- S973
-
The relation between negative symptoms and reward alterations before and after antipsychotic treatment in first episode patients with schizophreniaNielsen, M.Ø. / Wulff, S. / Rostrup, E. et al. | 2017
- S974
-
Interpersonal problems and personality disorder in Korean criminal offenders with schizophreniaChee, I.S. / Kim, Y. / Kwon, J. et al. | 2017
- S975
-
Psychiatric disorders in child and adolescent offspring of patients with schizophrenia and bipolar disorder: a four-year follow-up studyDe la Serna, E. / Sugranyes, G. / Romero, S. et al. | 2017
- S976
-
Do treatment goals impact treatment decisions among people recently diagnosed with schizophrenia?Bridges, J.F. / Beusterien, K. / Heres, S. et al. | 2017
- S977
-
Reward alterations in antipsychotic naive first episode psychosis before and after treatment with a partial dopamine agonistTangmose, K. / Nielsen, M.Ø. / Sigvard, A. et al. | 2017
- S978
-
Metabolic syndrome and schizophrenia: the role of substance abuseFerreira, C. / Castanheira, L. / Ferreira, L. et al. | 2017
- S979
-
Genetic variants within key nodes of the cascade of antipsychotic mechanisms: effects on treatment response and schizophrenia psychopathologyPorcelli, S. / Calabrò, M. / Crisafulli, C. et al. | 2017
- S980
-
Subjective interview quality metrics predict scoring performance in the administration of the PANSSNegash, S. / Echevarria, B. / Stein, L. et al. | 2017
- S981
-
Within person variance as a quality metric – an exploratory analysis identifying outlier sites in schizophrenia clinical trialsKott, A. / Wang, X. / Sachs, G. et al. | 2017
- S982
-
Social anxiety disorder among applicants to the psychiatry Master's Degree program in MalaysiaAzhar, F.L. / Gill, J.S. / Sulaiman, A.H. et al. | 2017
- S983
-
Neural substrates of fear conditioning are modulated by GLRB allelic variation: converging evidence from an independent replicationLueken, U. / Kuhn, M. / Yang, Y. et al. | 2017
- S984
-
Chronic social defeat stress: impact on sleep in susceptible miceHenderson, F. / Vialou, V. / El Mestikawy, S. et al. | 2017
- S985
-
Hypothalamic miR-132-3p changes in response to intracerebroventricular oxytocin: relevance for anxiety- and fear-related behaviourBludau, A. / Menon, R. / Meister, G. et al. | 2017
- S986
-
Circulating microRNAs as potential biomarkers of differential susceptibility to traumatic stressDe Nijs, L. / Krauskopf, J. / Snijders, C. et al. | 2017
- S987
-
Fibroblast growth factor-antisense overexpression in medial prefrontal cortex regulates anxiety-like behaviour in ratsEren Kocak, E. / Hokelekli, F.O. / Karatas-Kursun, H. et al. | 2017
- S988
-
Administration of para-chlorophenylalanine reduces both expression and acquisition of context-conditioned fearHagsäter, S.M. / Johansson, E. / Pettersson, R. et al. | 2017
- S989
-
From uncertainty to checking: the role of metacognitive monitoring in obsessive compulsive disorder (OCD)Baptista, A. / N'Diaye, K. / Mallet, L. et al. | 2017
- S990
-
Altered functional connectivity of the subthalamus and the bed nucleus of the stria terminalis in obsessive-compulsive disorderCano Català, M. / Alonso, P. / Martínez-Zalacaín, I. et al. | 2017
- S991
-
Prescribing practices in obsessive-compulsive disorder in ItalyMarazziti, D. / Mucci, F. / Tundo, A. et al. | 2017
- S992
-
Anxiety associated with a reduction of cardiovascular mortality risk in primary care population in LatviaIvanovs, R. / Kivite, A. / Mintale, I. et al. | 2017
- S993
-
Identification and comparison of workplace stressors in different profiles of health care workers in primary and secondary community health careTrifunovic, N. / Dzubur Kulenovic, A. / Jatic, Z. et al. | 2017
- S994
-
The 'Body keeps the score' revisited: changes in lipid levels and Coronary Disease risk in veterans suffering from chronic PTSDDzubur Kulenovic, A. et al. | 2017
- S995
-
Functional connectivity of premotor, sensorimotor and insular regions in obsessive-compulsive disorder patients with and without sensory phenomenaDel Cerro, I. / Subirà, M. / Alonso, P. et al. | 2017
- S996
-
Secondary traumatisation and some related outcomes in firefightersBastug, G. / Ergul Topcu, A. / Ergun, O.F. et al. | 2017
- S997
-
The prefrontal-amygdala circuit in trait anxiety and generalized anxiety disorder. Testing the boundaries between healthy and pathological worriesPorta, D. / Via, E. / Goldberg, X. et al. | 2017
- S998
-
Will early intervention with SSRI versus benzodiazepines reduce the risk of developing posttraumatic stress disorder?Frankova, I. et al. | 2017
- S999
-
Distinct contributions of obsessive and compulsive symptoms for whole-brain functional connectivity in obsessive-compulsive disorderMoreira, P. / Marques, P. / Magalhaes, R. et al. | 2017
- S1000
-
Common neurotransmission recruited in (R, S)-ketamine and (2R, 6R)-hydroxynorketamine-induced sustained antidepressant-like effectsPham, T.H. / Defaix, C. / Xu, X. et al. | 2017
- S1001
-
Reducing fear extinction deficits in a 5-HT2C receptor editing model of post-traumatic stress disordersRegue, M. / Martin, V. / Lanfumey, L. et al. | 2017
- S1002
-
Prevalence of anxiety and depressive symptoms in a Canadian medical cannabis use cohortVan Ameringen, M. / Simpson, W. / Turna, J. et al. | 2017
- S1003
-
Evaluating self-knowledge and self-control workshops for patients with anxiety disordersRomero Guillena, S.L. / Garcia Salguero, M. / Jimenez Hernandez, J.H. et al. | 2017
- S1004
-
Augmentation of serotonin reuptake inhibitors with antipsychotic drugs in treatment-resistant obsessive-compulsive disorder: a meta-analysisDold, M. / Aigner, M. / Kasper, S. et al. | 2017
- S1005
-
Neural plasticity following cognitive-behavioral therapy in panic disorder – the impact of comorbid depressionKunas, S.L. / Yang, Y. / Straube, B. et al. | 2017
- S1006
-
The effect of early maladaptive schema on the treatment outcomes of cognitive-behavioural group therapy for panic disorderLee, S.J. / Won, S.H. / Chang, S.M. et al. | 2017
- S1008
-
Panicolytic effect of naltrexone: a randomised clinical trialFranceschi Biagioni, A. / Freire, R.C.R. / Nardi, A.G. et al. | 2017
- S1009
-
Effects of escitalopram challenge on white matter diffusion in obsessive-compulsive disorder and healthy controlsRoos, A. / Fouche, J. / Stein, D. et al. | 2017
- S1010
-
Brain incorporation of different polyunsaturated fatty acids ratio and anxiety-like symptoms development in young rats supplemented with omega-3/-6Kuhn, F.T. / Bürger, M.E. / Dias, V.T. et al. | 2017
- S1012
-
MicroRNA signature associated with enhanced vulnerability to develop psychiatric disorders: dissecting the mechanisms by using an in vitro modelCattane, N. / Mariani, N. / Pariante, C. et al. | 2017
- S1013
-
Chronic stress targets adult hippocampal neurogenesis preferentially in the suprapyramidal blade of rat dorsal dentate gyrusAlves, N.D. / Patrício, P. / Correia, J.S. et al. | 2017
- S1014
-
Cold pressor pain in body focused repetitive behaviour disordersRedden, S.A. / Chamberlain, S.R. / Grant, J.E. et al. | 2017
- S1015
-
Sex-dependent differences in oxytocin receptor gene methylation between posttraumatic stress disorder patients and trauma-exposed healthy controlsNawijn, L. / Krzyzewska, I. / Van Zuiden, M. et al. | 2017
- S1016
-
Sucrose intake test as a tool to study vulnerability/resilience towards acute stressSala, N. / Musazzi, L. / Tornese, P. et al. | 2017
- S1017
-
Brain structural correlates of subclinical obsessive-compulsive symptoms in healthy childrenSunol, M. / Contreras-Rodríguez, O. / Macià, D. et al. | 2017
- S1018
-
Alcohol abuse in subjects developing or not post-traumatic stress disorder after trauma exposureFiori, F. / Vellante, F. / Sarchione, F. et al. | 2017
- S1019
-
Fragmented REM sleep contributes to slow dissolving of emotional distress and hyperarousal in insomniaWassing, R. / Schalkwijk, F. / Van Someren, E.J. et al. | 2017
- S1020
-
Cardiovascular reactions to psychosocial stress, Type D personality and trait anxiety in patients with coronary artery diseaseGecaite, J. / Burkauskas, J. / Brozaitiene, J. et al. | 2017
- S1022
-
Ghrelin mimetic MK-677 alleviates amyloid beta-related pathology in 5XFAD mice, an animal model of Alzheimer's diseaseLee, S.M. / Hong, M.H. / Chung, H.Y. et al. | 2017
- S1023
-
Effects of dimethyl fumarate treatment on adult neurogenesis in the streptozotocin-induced rat model of sporadic Alzheimer's diseaseKurowska, E. / Majkutewicz, I. / Podlacha, M. et al. | 2017
- S1024
-
The PDE4-inhibitor roflumilast improves memory: findings from a translational perspectiveVan Duinen, M.A. / Sambeth, A. / Heckman, P.R.A. et al. | 2017
- S1026
-
Cognitive function associated with depression in patients with Alzheimer's disease and the elderly without dementiaKim, D.H. / Moon, Y. / Yoon, K. et al. | 2017
- S1027
-
Cognitive impairment and plasma phoenixin levelGultekin, G. / Batun, G.C. / Yuruyen, M. et al. | 2017
- S1029
-
Antidepressants and anxiolytics in cognitive impairment: conclusions of a longitudinal studyCenalmor Aparicio, C. / Cabello de Alba, S.M. / Crespo Generelo, T. et al. | 2017
- S1030
-
Classification and prediction of neuropathological change of Alzheimer's disease using machine learning and MRIKautzky, A. / Seiger, R. / Hahn, A. et al. | 2017
- S1031
-
Mitochondria-targeted antioxidant SkQ1 reduces the death of dopaminergic neurons in the model of Parkinson's disease in micePavshintcev, V. / Podshivalova, L. / Averina, O. et al. | 2017
- S1032
-
Genetic variants of SNCA, risk of Parkinson's disease and alpha-synuclein level in CD45+ blood cellsKulabukhova, D. / Garaeva, L.A. / Emelyanov, A.K. et al. | 2017
- S1033
-
Patient-specific and in vitro models for the analysis of late-onset Alzheimer's diseaseEhrhardt, T. / Jung, M. / Hartmann, C. et al. | 2017
- S1034
-
Behavioral impairments after intranasal administration of alpha-synuclein oligomers in aged miceKalinin, I. / Solovieva, O.A. / Proshin, A.T. et al. | 2017
- S1035
-
The statistical analysis of the changes of the depressive mental states of Japanese patients with subacute myelo-optico neuropathyKonishi, T. et al. | 2017
- S1036
-
Myasthenia gravis: co-morbid psychiatric disorders and use of psychotropic medicationMachado, C. / Almeida, B. / Fragoeiro, C. et al. | 2017
- S1037
-
P300 parameters as markers for early stages of subcortical vascular neurocognitive disorder and treatment efficacyLevada, O.A. / Cherednichenko, N.V. / Troyan, A.S. et al. | 2017
- S1038
-
Ten-day cognitive training program combined with transcranial direct current stimulation (tDCS) in stroke rehabilitation – a sham controlled studySzépfalusi, N. / Németh, V.L. / Vékony, T. et al. | 2017
- S1039
-
Predictive genetic model for levodopa-induced dyskinesia in patients with Parkinson's diseaseIvanova, S.A. / Alifirova, V.M. / Freidin, M.B. et al. | 2017
- S1040
-
Antipsychotics without psychosis: exploratory study in Portuguese nursing homesFerreira, A.R. / Moreira, E. / Guedes, J. et al. | 2017
- S1041
-
Anterograde amnesia following a hanging attempt: a case reportGoren, Y. / Glik, A. / Steinmetz, A. et al. | 2017
- S1042
-
Psychopathology variables in neck-pain patientsHenry, M. / Henry-González, A.A. / Morera-Fumero, A. et al. | 2017
- S1043
-
The effect of melatonin and zinc on primary insomnia in elderly patientsHenry, M. / Henry-González, A.A. / Morera-Fumero, A. et al. | 2017
- S1044
-
Effects of chronic alcoholisation and ethanol withdrawal on expression of OX1R orexin brain receptors in ratsShabanov, P.D. / Sekste, E.A. / Airapetov, M.I. et al. | 2017
- S1045
-
Prenatal alcohol exposure disrupts dopamine-related gene expression in the rat midbrainRazumkina, E. / Nizharadze, M. / Anokhin, P. et al. | 2017
- S1046
-
Functional inactivation of accumbens disrupts context-induced reinstatement of alcohol seeking in ratsBianchi, P.C. / Leão, R.M. / Palombo, P. et al. | 2017
- S1047
-
Study of the effects of caffeinated/sugared energy drinks on ethanol craving, in ratsRomano, J.J. / Nassis, C.Z. / Petri, G. et al. | 2017
- S1048
-
Neural correlates of the anticipation of a sip of beer in young adult malesGroefsema, M.M. / Luijten, M. / Engels, R.C.M.E. et al. | 2017
- S1049
-
Association of gamma-glutamyl transferase (GGT) with risk of alcohol use behavioursKim, J.W. / Lee, B.C. / Choi, I.G. et al. | 2017
- S1051
-
The impact of positive and negative emotional states vs. comorbid depression or anxiety diagnoses on alcohol consumption in male and female alcoholicsKarpyak, V. / Geske, J.R. / Hall-Flavin, D.K. et al. | 2017
- S1054
-
A high working memory load preceding alcohol cue exposure, reduces the desire for alcohol in non-treatment seeking problem drinkersKaag, A.M. / Pattij, T. / De Vries, T.J. et al. | 2017
- S1055
-
Neuropsychological correlates of as-needed pharmacotherapy in alcohol dependence: double-blind placebo control study with the opioid antagonist nalmefeneGál, B.I. / Kilencz, T. / Albert, A. et al. | 2017
- S1056
-
Affective temperaments in alcohol dependence: influence of depressionGuldner, C. / Mohamed, M. / Bourdel, M.C. et al. | 2017
- S1057
-
Association between CACNA1C gene rs1034936 polymorphism and alcoholism in bipolar disorderMosheva, M. / Popovic, D. / Stukalin, Y. et al. | 2017
- S1058
-
The influence of co-administration of mephedrone and nicotine on anxiety- and memory-related behaviours and nicotine-induced sensitization in miceBiala, G. / Kaszubska, K. / Kruk-Slomka, M. et al. | 2017
- S1060
-
Combination of pregabalin with morphine: reinforcing and inhibiting effectsVashchinkina, E. / Vekovischeva, O. / Piippo, O. et al. | 2017
- S1061
-
The role of chronic stress on addictive vulnerability – focus on the nucleus accumbensLima, C. / Morgado, P. / Marques, F. et al. | 2017
- S1063
-
Impact of repeated administration of cocaine on the expression of genes involved in cholesterol metabolism in the rat brainAlsebaaly, J. / Rabbaa Khabbaz, L. / Dugast, E. et al. | 2017
- S1064
-
BDNF alterations in nucleus accumbens shell during morphine withdrawalGeoffroy, H. / Marie, N. / Noble, F. et al. | 2017
- S1064
-
Cue reactivity and opioid blockade in amphetamine dependence: a randomised, controlled fMRI studyGuterstam, J. / Jayaram Lindström, N. / Berrebi, J. et al. | 2017
- S1066
-
Naltrexone modulates dopamine release following chronic, but not acute amphetamine administration – a translational studyJayaram-Lindström, N. et al. | 2017
- S1068
-
Substance-induced psychotic disorders in an acute psychiatric inpatient unitFernandez-Quintana, A. / Quiroga-Fernández, C. / Novo-Ponte, A. et al. | 2017
- S1070
-
SLC6A2 genotype variation and the modulatory effects of atomoxetine on inhibitory control in individuals with and without cocaine use disorderLe, A.N. / Ziauddeen, H. / Fernandez-Egea, E. et al. | 2017
- S1071
-
Demographic and clinical profile of cannabis users in SingaporePezhummoottil Vasudevan Nair, A. / Guo Zheng, T. / Kumar, D. et al. | 2017
- S1073
-
The effect of methylphenidate on executive functioning in patients with co-morbid ADHD and stimulant use disorderBrynte, C. / Konstenius, M. / Jayaram-Lindström, N. et al. | 2017
- S1074
-
Alcohol use disorders in patients with cannabis dependence seeking treatmentDervaux, A. / Bourdel, M. / Krebs, M. et al. | 2017
- S1075
-
Opioid maintenance therapy for the treatment of opioid use disorders in outpatients with or without schizophreniaBouton, J.F. / Laqueille, X. / Bourdel, M.C. et al. | 2017
- S1076
-
Six-month follow up of patients with dual pathology in a community mental health settingNovo Ponte, A. / Fernandez Quintana, A. / Quiroga Fernandez, C. et al. | 2017
- S1077
-
Can cytokines serve as biomarkers of current cocaine use?Milpied, T. / Vorspan, F. / Etain, B. et al. | 2017
- S1079
-
Predicting adolescent smoking using fMRI – a possible predisposing role for inhibitory control and reward processing in addictive behavioursJollans, L. / Whelan, R. et al. | 2017
- S1080
-
Neural activity in response to smoking-related and neutral pictures in three different states in smokersSteinegger, C. / Engeli, E. / Kirschner, M. et al. | 2017
- S1081
-
Relationship between cyberaddiction and social anxiety among students in medicine: about 188 studentsAmamou, B. / Ben Hawala, A. / Mhalla, A. et al. | 2017
- S1082
-
Is impulsivity the only trait that matters in addictive behaviour?Crisan, G. / Manea, M.M. / Miron, A. et al. | 2017
- S1083
-
Why do addicted people participate in research?Morán-Sánchez, I. / Luna, A. / Rodríguez-Hernández, A. et al. | 2017
- S1084
-
Higher emotional eating scores before a nutritional treatment in patients with obesity moderates the development of binge eating disorderMallardo, L. / Santangelo, A. / Mannucci, E. et al. | 2017
- S1085
-
Sexual addiction in Tunisia: an exploration of prevalence, socio-demographic characteristics and self esteemMissaoui, C. / Amamou, B. / Mhalla, A. et al. | 2017
- S1086
-
Relation between food addiction and nutritional status in patients candidates for bariatric surgeryFuentes, M. / Gabler, G. / Silva, J. et al. | 2017